MacroGenics reported 1.41M in Interest Income for its fiscal quarter ending in June of 2025.


Interest Income Change Date
AbbVie USD 73M 19M Mar/2025
AstraZeneca 68M 16M Jun/2025
Biogen USD 32.3M 8.4M Jun/2025
Daiichi Sankyo 9.96B 230M Mar/2024
Eli Lilly USD 40M 8.3M Jun/2025
Genmab DKK 25M 8M Jun/2025
Geron USD 4.66M 496K Jun/2025
Gilead Sciences 73M 21M Jun/2025
J&J 332M 51M Mar/2025
MacroGenics 1.41M 1.41M Jun/2025
Merck USD 109M 37M Mar/2025
Pfizer USD 156M 13M Jun/2025
Regeneron Pharmaceuticals 174.8M 1.3M Jun/2025
Roche Holding 2M 12M Dec/2020
Xencor USD 7.25M 290K Jun/2025